SG4795G - Process for preparing optically active 2-oxoimidazzolidine derivatives - Google Patents

Process for preparing optically active 2-oxoimidazzolidine derivatives

Info

Publication number
SG4795G
SG4795G SG4795A SG4795A SG4795G SG 4795 G SG4795 G SG 4795G SG 4795 A SG4795 A SG 4795A SG 4795 A SG4795 A SG 4795A SG 4795 G SG4795 G SG 4795G
Authority
SG
Singapore
Prior art keywords
optically active
oxoimidazzolidine
derivatives
preparing optically
group
Prior art date
Application number
SG4795A
Other languages
English (en)
Inventor
Kimiaki Hayashi
Hitoshi Kubota
Original Assignee
Tanabe Seiyaku Co., Ltd.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co., Ltd., filed Critical Tanabe Seiyaku Co., Ltd.,
Priority to SG4795A priority Critical patent/SG4795G/en
Publication of SG4795G publication Critical patent/SG4795G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SG4795A 1988-12-16 1995-01-13 Process for preparing optically active 2-oxoimidazzolidine derivatives SG4795G (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG4795A SG4795G (en) 1988-12-16 1995-01-13 Process for preparing optically active 2-oxoimidazzolidine derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63318745A JPH0645603B2 (ja) 1988-12-16 1988-12-16 光学活性２‐オキソイミダゾリジン誘導体の製法
SG4795A SG4795G (en) 1988-12-16 1995-01-13 Process for preparing optically active 2-oxoimidazzolidine derivatives

Publications (1)

Publication Number Publication Date
SG4795G true SG4795G (en) 1995-06-16

Family

ID=18102470

Family Applications (1)

Application Number Title Priority Date Filing Date
SG4795A SG4795G (en) 1988-12-16 1995-01-13 Process for preparing optically active 2-oxoimidazzolidine derivatives

Country Status (17)

Country Link
US (1) US5013845A (fr)
EP (1) EP0373881B1 (fr)
JP (1) JPH0645603B2 (fr)
KR (1) KR950009364B1 (fr)
CN (1) CN1032308C (fr)
AT (1) ATE100817T1 (fr)
AU (1) AU622959B2 (fr)
CA (1) CA2004606C (fr)
DE (1) DE68912745T2 (fr)
DK (1) DK174701B1 (fr)
ES (1) ES2062044T3 (fr)
FI (1) FI97133C (fr)
HK (1) HK34195A (fr)
HU (1) HU203730B (fr)
IE (1) IE64315B1 (fr)
IL (1) IL92456A0 (fr)
SG (1) SG4795G (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513292A (zh) * 2013-09-29 2015-04-15 山东新时代药业有限公司 一种雷米普利的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5788165A (en) * 1980-11-21 1982-06-01 Tanabe Seiyaku Co Ltd 2-oxoimidazolidine-4-carboxylic acid derivative and its preparation
JPS6058233B2 (ja) * 1982-05-24 1985-12-19 田辺製薬株式会社 ２−オキソイミダゾリジン誘導体及びその製法
JPS6058233A (ja) * 1983-08-11 1985-04-04 ザ・アプジヨン・カンパニー 滅菌懸濁液及び溶液の保持及び混合装置

Also Published As

Publication number Publication date
IE64315B1 (en) 1995-07-26
DE68912745T2 (de) 1994-05-11
DK174701B1 (da) 2003-09-29
JPH0645603B2 (ja) 1994-06-15
ATE100817T1 (de) 1994-02-15
FI97133C (fi) 1996-10-25
JPH02164869A (ja) 1990-06-25
EP0373881A2 (fr) 1990-06-20
DE68912745D1 (de) 1994-03-10
HU896640D0 (en) 1990-02-28
CA2004606C (fr) 1997-01-07
HK34195A (en) 1995-03-17
US5013845A (en) 1991-05-07
AU4619589A (en) 1990-06-21
CN1043705A (zh) 1990-07-11
HU203730B (en) 1991-09-30
DK638289A (da) 1990-06-17
FI97133B (fi) 1996-07-15
CN1032308C (zh) 1996-07-17
HUT52064A (en) 1990-06-28
IE894004L (en) 1990-06-16
KR950009364B1 (ko) 1995-08-21
CA2004606A1 (fr) 1990-06-16
EP0373881A3 (en) 1990-08-16
DK638289D0 (da) 1989-12-15
ES2062044T3 (es) 1994-12-16
IL92456A0 (en) 1990-08-31
FI895795A0 (fi) 1989-12-04
KR900009603A (ko) 1990-07-05
AU622959B2 (en) 1992-04-30
EP0373881B1 (fr) 1994-01-26

Similar Documents

Publication Publication Date Title
AU643489B2 (en) Antibacterial agents - II
HU913396D0 (en) Process for the production of azasteroide compounds and medical preparations containing them as active agents
HUT41386A (en) Process for preparing 1-substituted oxindole-3-carboxamide derivatives
AU2044697A (en) Phenylalkylcarboxylic acid derivatives
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
NO174848C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte
EP0331078A3 (fr) Procédé de préparation de dérivés optiquement actifs de l'acide 4-oxo-benzopyranne-2-carboxylique et leurs intermédiaires
EP0373881A3 (en) Process for preparing optically active 2-oxoimidazolidine derivatives
EP0555479A4 (fr)
AU3805889A (en) Process for the synthesis of optically active aminoacids
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
EP0432841A3 (en) Spiro-indoline-oxazine compounds with photochromatic and photosensitizing characteristics and the process for their preparation
DK424888A (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
GR3006108T3 (fr)
AU4532889A (en) A process for the preparation of tripeptides
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona